Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease - Wikidata - wikimedia - TriplyDB

Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease

Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease

http://www.wikidata.org/entity/Q34181641

about

Surgical pathology of early stage non-small cell lung carcinoma Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS)Recent clinical innovations in thoracic surgery in Hong Kong Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas.Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.Is spread through alveolar spaces, the newly recognized pattern of invasion, a potential game changer in lung adenocarcinoma?Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations The importance of the lepidic component as a prognostic factor in stage I pulmonary adenocarcinoma.Correlation between histological invasiveness and the computed tomography value in pure ground-glass nodules Pure ground-glass opacity on chest computed tomography: predictive factors for invasive adenocarcinoma Chylothorax and Recurrent Laryngeal Nerve Injury Associated With Robotic Video-Assisted Mediastinal Lymph Node Dissection Risk factors for recurrence after sublobar resection in patients with small (2 cm or less) non-small cell lung cancer presenting as a solid-predominant tumor on chest computed tomography.Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.Size of Non-lepidic Invasive Pattern Predicts Recurrence in Pulmonary Mucinous Adenocarcinoma: Morphologic Analysis of 188 Resected Cases with Reappraisal of Invasion Criteria.Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons.Lymphatic invasion is a more significant prognostic factor than visceral pleural invasion in non-small cell lung cancer with tumours of 3 cm or less.Classification of different patterns of pulmonary adenocarcinomas.Computed Tomography Screening for Lung Cancer: Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid Nodules.Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma.Diagnosis of lung adenocarcinoma in situ and minimally invasive adenocarcinoma from intraoperative frozen sections: an analysis of 136 cases.KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules.Proposals for revisions of the classification of lung cancers with multiple pulmonary sites: the radiologist's, thoracic surgeon's and oncologist's point of view.The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma.Clinical characteristics and programmed cell death ligand-1 expression in adenocarcinoma in situ and minimally invasive adenocarcinoma of lung.Histopathologic and molecular approach to staging of multiple lung nodules.Peripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA-135b overexpression are more likely to invade visceral pleura.GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?[Grading of lung cancer].Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression.Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases.Prognostic significance of histologic classification and tumor disappearance rate by computed tomography in lung cancer.Will spread through air spaces be a staging parameter in lung cancer?Solid component proportion is an important predictor of tumor invasiveness in clinical stage T1N0M0 (cT1N0M0) lung adenocarcinoma.

P2860

Q26739713-6D143E3C-5CAC-4E4D-95CD-6B2719C14019 Q27009370-6C1334EA-0E99-489D-92CA-87BDCC44EAF2 Q28070217-A8AD2BCA-3EF8-43AD-90C8-8EA0C0EEADA3 Q31034428-9FB54940-0A1A-4F7F-AD3E-331FE215C4D9 Q34748124-359511C3-A285-4815-BE56-7A50C1E51CAE Q35838494-F10D961C-FE72-4F80-80C6-063D8BB8D228 Q35845212-6417E894-51B1-4842-8717-2FF7B76EC6A1 Q35954585-E9F4FDFE-6524-4A84-88E2-9C8790B11F77 Q36197300-F8544381-46F5-4613-970A-E3FBAE183A43 Q36430666-006AEAAC-BB98-43BC-B836-9492CFC75060 Q36540385-5EA56732-D6E1-4439-B5C0-5D866DBA3974 Q36583814-4F9202A5-4401-4227-9C81-F0388DDBF44D Q36761771-67D8F35A-B9A4-408B-9851-723D1D0A499B Q37121389-D56760C6-E4C6-4BC8-9169-6C100998A1B1 Q37169075-EDFF5EF0-8578-4DB3-9D71-8BF44C7E89FA Q37208639-6FF93357-619D-40EC-8D38-C40A9485792B Q37329374-F873FFA3-7AD3-4F47-AE2D-8696503B4F2E Q37607959-3F2F3FE5-2E85-4CC3-BE58-D99014F12708 Q38270567-07A3BFFA-7231-481F-8A3A-DEF3BC37FA48 Q38404058-F1122D92-151C-4A5B-910A-B4A83BA9BCC0 Q38574971-98387151-3B99-481F-BFCB-87285F87F2D6 Q38845939-173B6403-4E12-4C26-995D-E8022AAF8D78 Q39293400-93C8644E-9313-4FCD-87CB-2E19A22AA929 Q39769769-464BB5B7-C120-4986-847C-2D777F210C7A Q40542208-1FA83824-FF15-44B1-996B-AC50901A5837 Q40812047-B9EAE7A9-0BFB-4C71-98C4-7CE11AB5ED9D Q41113925-CBCCF9FF-F1D7-47D1-B800-529B04F5ED41 Q41153904-93B548DB-E02C-4889-A666-793CCF6CE13C Q47117334-DF0D63A0-E470-43DF-9CB3-3CA84ED17F7E Q47144893-D23257CC-89F9-42BE-BD12-B56ADCC80172 Q47152233-DE651A55-B7FE-405D-99CA-FD749F5F051B Q47676925-660D1FE1-F9FF-4ACB-B762-A72E2B1F8CC9 Q52639668-C348DBE0-0CE5-46D0-9F50-DCFB85D87D0F Q53076283-1C03C2A9-E243-4CD4-B7FB-A5B708A00F5C Q54254003-11381F6D-654A-4ACB-8F32-152F80E619B8 Q54980290-925A65D6-C4C7-47B3-AA44-6A50827E66E6 Q54989900-3FC5EEA7-B7D7-4A95-838E-D19D62B8A6D1 Q55100998-AA371297-A538-4FD3-A8EE-FEB90ACB36DB Q55155344-2C4BE58A-2E4D-4373-BC4E-C521409A3A79 Q55344487-C47870CD-B6B0-48C4-9BFD-B50908652861

P2860

Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease

http://www.wikidata.org/entity/Q34181641

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prognostic significance of ade ...... patients with stage I disease

@ast

Prognostic significance of ade ...... patients with stage I disease

@en

Prognostic significance of ade ...... patients with stage I disease

@nl

type

label

Prognostic significance of ade ...... patients with stage I disease

@ast

Prognostic significance of ade ...... patients with stage I disease

@en

Prognostic significance of ade ...... patients with stage I disease

@nl

prefLabel

Prognostic significance of ade ...... patients with stage I disease

@ast

Prognostic significance of ade ...... patients with stage I disease

@en

Prognostic significance of ade ...... patients with stage I disease

@nl

P1433

Q34181641-FD94F715-729F-4219-BF87-A2528D6B970F

P1476

Q34181641-89E42BF0-DFE1-4E9C-B36A-B4765F21718D

P2093

Q34181641-0B4630A1-A9A3-4164-8FAA-60AA6219D75F

Q34181641-69CFBAA8-CDC2-41C5-B72D-A8457B0B6362

Q34181641-78E4A42A-2EEF-46DB-AD62-1073E8067854

Q34181641-B82E328A-9B6C-4866-8E25-72455BE7A97B

Q34181641-BA1BCC32-5A98-4654-BE7F-9620E1B9F189

Q34181641-F269D7F8-FED3-461A-A95D-8D2F6A511967

P2860

Q34181641-0CE931DE-3EB8-48D9-960E-065C1029B424

Q34181641-21533C90-4F9A-4FB6-9D07-69C3526000F1

Q34181641-22FC9B6D-EBC5-4EA4-BB81-0DB3D90489CC

Q34181641-26953888-E6B7-4D58-9EB9-B10625FF627A

Q34181641-325AFA09-2419-4B48-B6E8-F9C4154A25DB

Q34181641-3525014D-DBEA-4B75-A532-393115131781

Q34181641-3BC9409D-74DF-4ACA-A7AF-A0036B02B75E

Q34181641-4052E8D4-7D84-47B6-AF7E-1D65851618EE

Q34181641-45DC4FC9-4D1A-446A-8D66-5BC461C792AF

Q34181641-57BABD6C-21EE-4C0A-8BFF-423202291FCB

P304

Q34181641-D040E97E-1F8A-464A-A619-2D15C8AA9381

P31

Q34181641-317FB594-4F20-404A-A7A6-BF225BCF8B9B

P356

Q34181641-E54D4395-F422-4303-93E9-484D6ECD1F69

P407

Q34181641-79B02198-A6E1-49F7-9B5C-5C75B0D3EAA2

P433

Q34181641-3D7BCFC1-87C9-405B-BA06-946B176F3D91

P478

Q34181641-66A43866-1A34-4DE6-9C1F-4535F4F29542

P50

Q34181641-27ACC0AE-AC93-49F9-80E9-3AB0EDAEB0C6

Q34181641-5D9D6AB0-AE45-4D16-B245-8D5352D56739

Q34181641-77C7897A-65F0-4876-8B8D-9F770F0CE141

P577

Q34181641-78F84DE7-41AF-460F-94D2-38BD87BF7B8B

P5875

Q34181641-D005A7F4-B2BC-4A9E-8E1A-B32F61F3E283

P698

Q34181641-3840E8DE-8569-4100-B29A-615A7056FE4F

P921

Q34181641-1239840F-F1F8-40B4-9826-A382B14556BE

Q34181641-3A34AE59-F828-4EC0-A9CA-70C147B35D6F

P932

Q34181641-E342AD9F-AF5C-45B5-B8C9-AB9E257605D8

P356

PAS.0000000000000134

P1433

The American Journal of Surgical Pathology

P1476

Prognostic significance of ade ...... patients with stage I disease

@en

P2093

Akihiko Yoshizawa

http://www.w3.org/2001/XMLSchema#string

Camelia S Sima

http://www.w3.org/2001/XMLSchema#string

Gregory J Riely

http://www.w3.org/2001/XMLSchema#string

Jonathan Villena-Vargas

http://www.w3.org/2001/XMLSchema#string

Kyuichi Kadota

http://www.w3.org/2001/XMLSchema#string

Prasad S Adusumilli

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Reduced lung-cancer mortality with low-dose computed tomographic screening

Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features

Small adenocarcinoma of the lung. Histologic characteristics and prognosis

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.

P304

448-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PAS.0000000000000134

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

William D. Travis

Valerie W Rusch

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259959528

http://www.w3.org/2001/XMLSchema#string

P698

24472852

http://www.w3.org/2001/XMLSchema#string

P921

P932

4164170

http://www.w3.org/2001/XMLSchema#string